With 4.0 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.99 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $3.1400 whereas the lowest price it dropped to was $2.7701. The 52-week range on CGC shows that it touched its highest point at $20.80 and its lowest point at $2.76 during that stretch. It currently has a 1-year price target of $4.02. Beta for the stock currently stands at 1.20.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CGC was up-trending over the past week, with a rise of 0.98%, but this was down by -12.50% over a month. Three-month performance dropped to -43.49% while six-month performance fell -75.36%. The stock lost -84.83% in the past year, while it has lost -39.73% so far this year. A look at the trailing 12-month EPS for CGC yields -16.06 with Next year EPS estimates of -0.81. For the next quarter, that number is -0.33. This implies an EPS growth rate of 90.94% for this year and 83.41% for next year. EPS is expected to grow by 13.28% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -76.81%.
Float and Shares Shorts:
At present, 91.11 million CGC shares are outstanding with a float of 73.89 million shares on hand for trading. On Feb 29, 2024, short shares totaled 4.6 million, which was 5.05% higher than short shares on Jan 31, 2024. In addition to CGC as the firm’s Canopy Growth Corporation, KGC serves as its Kinross Gold Corporation.
Institutional Ownership:
Through their ownership of 4.90% of CGC’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CGC since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
Dividends & Yield:
In terms of dividends, CGC has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and CGC currently yields $0.00. In the past year, CGC’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, CGC has a current buyback yield of $––. This was $–– for the TTM, and it was $–– for the past five years.